References
- Dhar Chowdhury S, Oommen A. Epidemiology of COVID-19. J Dig Endosc. 2020;11(1):03–07. doi:10.1055/s-0040-1712187
- Office WHOEMR. Updated Clinical Management Guidelines for COVID-19. Vol. 13. Weekly Epidemiology Monitor; 2020.
- Khandia R, Singhal S, Alqahtani T, et al. Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic. Environ Res. 2022;209:112816. doi:10.1016/j.envres.2022.112816
- COVID 19 Dashboard: Saudi Arabia. Gov.sa; 2022. Available from: https://covid19.moh.gov.sa/. Accessed June 13, 2022.
- Reuters Graphics. Saudi Arabia: the latest coronavirus counts, charts and maps. Reuters; 2020. Available from: https://graphics.reuters.com/world-coronavirus-tracker-and-maps/countries-and-territories/saudi-arabia. Accessed June 13, 2022.
- da Rosa Mesquita R, Francelino Silva Junior LC, Santos SFM, et al. Clinical manifestations of COVID-19 in the general population: systematic review. Wien Klin Wochenschr. 2021;133(7–8):377–382. doi:10.1007/s00508-020-01760-4
- Saudi MoH protocol for patients suspected of/confirmed with COVID-19 Supportive care and antiviral treatment of suspected or confirmed COVID-19 infection [Internet]; 2022. Available from: https://www.moh.gov.sa/Ministry/MediaCenter/Publications/Documents/MOH-therapeutic-protocol-for-COVID-19.pdf. Accessed June 13, 2022.
- World Health Organization. Saudi Arabia: WHO Coronavirus disease (COVID-19) dashboard with vaccination data [Internet]; 2022. Available from: https://covid19.who.int/region/emro/country/sa. Accessed June 13, 2022.
- Ehreth J. The global value of vaccination. Vaccine. 2003;21(7–8):596–600. doi:10.1016/s0264-410x(02)00623-0
- Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162B2 mrna covid-19 vaccine. N Engl J Med. 2020;383(27):2603–2615. doi:10.1056/NEJMoa2034577
- Sadoff J, Gray G, Vandebosch A, et al. Safety and efficacy of single-dose Ad26.COV2.S vaccine against covid-19. N Engl J Med. 2021;384(23):2187–2201. doi:10.1056/NEJMoa2101544
- Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mrna-1273 SARS-COV-2 vaccine. N Engl J Med. 2021;384(5):403–416. doi:10.1056/NEJMoa2035389
- World Health Organization. COVID-19 vaccines advice. [ cited 2022 Feb 4]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice. Accessed June 13, 2022.
- Saudi Press agency. SFDA approves registration of Pfizer-BioNTech COVID-19 vaccine; 2020. Available from: https://www.spa.gov.sa/viewfullstory.php?lang=en&newsid=2166947. Accessed June 13, 2022.
- Saudi Food & Drug Authority. Saudi food & drug authority allows the import and use of AstraZeneca covid 19 vaccine; 2021. Available from: https://sfda.gov.sa/en/news/79059. Accessed June 13, 2022.
- Tenforde MW, Self WH, Adams K, et al. Association between mrna vaccination and COVID-19 hospitalization and disease severity. JAMA. 2021;326(20):2043–2050. doi:10.1001/jama.2021.19499
- Alwafi H, Naser AY, Qanash S, et al. Predictors of length of hospital stay, mortality, and outcomes among hospitalised COVID-19 patients in Saudi Arabia: a Cross-Sectional Study. J Multidiscip Healthc. 2021;14:839–852. doi:10.2147/JMDH.S304788
- Lopez Bernal J, Andrews N, Gower C, et al. Effectiveness of the pfizer-biontech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ. 2021:n1088. doi:10.1136/bmj.n1088
- Bahl A, Johnson S, Maine G, et al. Vaccination reduces need for emergency care in breakthrough COVID-19 infections: a multicenter cohort study. Lancet Reg Health Am. 2021;4:100065. doi:10.1016/j.lana.2021.100065
- Henry BM, Aggarwal G, Wong J, et al. Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: a pooled analysis. Am J Emerg Med. 2020;38(9):1722–1726. doi:10.1016/j.ajem.2020.05.073
- Hussein AM, Taha ZB, Gailan Malek A, et al. D-dimer and serum ferritin as an independent risk factor for severity in COVID-19 patients. Materials Today. 2021. doi:10.1016/j.matpr.2021.04.009
- Liu F, Li L, Xu MD, et al. Prognostic value of interleukin-6, C-reactive protein, and Procalcitonin in patients with covid-19. J Clin Virol. 2020;127:104370. doi:10.1016/j.jcv.2020.104370
- Singh C, Naik B, Pandey S, et al. Effectiveness of COVID-19 vaccine in preventing infection and disease severity: a case-control study from an Eastern State of India. Epidemiol Infect. 2021;149:E224. doi:10.1017/S0950268821002247
- Mhawish H, Mady A, Alaklobi F, et al. Comparison of severity of immunized versus non-immunized COVID-19 patients admitted to ICU: a prospective observational study. Ann Med Surg. 2021;71:102951. doi:10.1016/j.amsu.2021.102951
- Olson SM, Newhams MM, Halasa NB, et al. Effectiveness of BNT162B2 vaccine against critical covid-19 in adolescents. N Engl J Med. 2022;386(8):713–723. doi:10.1056/nejmoa2117995
- Moghadas SM, Vilches TN, Zhang K, et al. The impact of vaccination on coronavirus disease 2019 (COVID-19) outbreaks in the United States. Clin Infect Dis. 2021;73(12):2257–2264. doi:10.1093/cid/ciab079
- Haas EJ, Angulo FJ, McLaughlin JM, et al. Impact and effectiveness of mrna BNT162b2 vaccine against SARS-COV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using National Surveillance Data. Lancet. 2021;397(10287):1819–1829. doi:10.1016/s0140-6736(21)00947-8
- Kaura A, Trickey A, Shah AS, et al. Comparing the longer-term effectiveness of a single dose of the pfizer-biontech and Oxford-AstraZeneca covid-19 vaccines across the age spectrum. eClinicalMedicine. 2022;46:101344. doi:10.1016/j.eclinm.2022.101344
- Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in covid-19 pneumonia – a systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. 2020;14(4):395–403. doi:10.1016/j.dsx.2020.04.018
- Xu J, Xiao W, Liang X, et al. A meta-analysis on the risk factors adjusted association between cardiovascular disease and covid-19 severity. BMC Public Health. 2021;21(1). doi:10.1186/s12889-021-11051-w
- Statsenko Y, Al Zahmi F, Habuza T, et al. Impact of age and sex on covid-19 severity assessed from radiologic and clinical findings. Frontiers. 2022;2022:1395. doi:10.3389/fcimb.2021.777070
- Marik PE, DePerrior SE, Ahmad Q, Dodani S. Gender‐based disparities in COVID-19 patient outcomes. J Investig Med. 2021;69(4):814–818. doi:10.1136/jim-2020-001641
- Livanos AE, Jha D, Cossarini F, et al. Gastrointestinal involvement attenuates COVID-19 severity and mortality. MedRxiv. 2020. doi:10.1101/2020.09.07.20187666
- Coronavirus disease (covid-19): Vaccines. World Health Organization; 2022. Available from: https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-covid-19-vaccines?gclid=Cj0KCQjwmuiTBhDoARIsAPiv6L91ecmYWZ16a2_QXNynlgUKnClcrua0JQ38PywMl763wN1n85tGGAcaApfuEALw_wcB&topicsurvey=v8kj13. Accessed June 13, 2022.
- Loo KY, Letchumanan V, Ser HL, et al. Covid-19: insights into potential vaccines. Microorganisms. 2021;9(3):605. doi:10.3390/microorganisms9030605